SOFT TISSUE PATHOLOGY
SOFT TISSUE PATHOLOGY
Biopsy Site
The muscle with maximal clinical signs should NOT be selected since it would likely produce an uninformative 'end-stage' biopsy comprising mainly fat and connective tissue. Muscles showing minimum clinical signs are helpful in elucidating pathological aetiology. Also avoid muscles which have recently suffered trauma - including EMG or BIOPSY needles! Common sampling sites (for which there is much normal data) include:-
|
Quadriceps femoris (lateral aspect)
|
histological and histochemistry procedures
Category
|
Method
|
Enzyme
|
Use
|
Morphology
|
Toluidine blue
|
|
General appearance and orientation
|
|
Haematoxylin and eosin*
|
|
Muscle fibre architecture, nuclear position and number, degeneration and regeneration, hyaline fibres, fibrosis.
|
|
Van Giesson
|
|
Fibrosis
|
|
Masson's trichrome
|
|
Fibrosis
|
|
Modified Gomori trichrome
|
|
Nemaline rods and 'ragged-red' fibres
|
Fibre Typing
|
Myofibrillar ATPase*
(pH 4.3, 4.6, 10.2)
|
|
Types I, IIa, IIb, IIc
Type grouping
|
Enzymes - Oxidative
|
NADH-Tr*
|
EC 1.6.4.3
|
Mitochondrial and tubular aggregates
|
|
Succinate dehydrogenase
|
|
Mitochondria
|
|
Cytochrome oxidase
|
EC 1.9.3.1
|
Mitochondria, enzyme deficiency
|
Enzymes - Glycolytic
|
Phosphorylase*
|
EC 2.4.1.1
|
Enzyme deficiency
|
|
Phosphofructokinase
|
EC 2.7.1.11
|
Enzyme deficiency
|
Enzymes - Hydrolytic
|
Acid phosphatase
|
EC 3.1.3.2
|
Inflammation, lysosomes
|
|
Non-specific esterase*
|
EC 3.1.1.8
|
Inflammation, lysosomes
|
|
Acetylcholinesterase
|
EC 3.1.1.7
|
Neuromuscular and myotendinous junctions
|
Storage
|
PAS*
|
|
Glycogen, carbohydrate
|
|
Alcian blue
|
|
Mucopolysaccharide
|
|
Sudan black B
|
|
Lipid
|
|
Oil red O*
|
|
Lipid
|
Other
|
Methyl green pyronine
|
|
RNA
|
|
Acridine orange
|
|
RNA
|
|
Von Kossa
|
|
Calcium
|
Investigation of the Patient with a suspected Neuromuscular Disorder
Family History: acquired or genetic disorder?
|
Clinical History and Examination: acute or chronic, age of onset, rate of progression, anatomical distribution of weakness (MRC ratings), wasting or pain
|
Muscle Biopsy: myopathic or neurogenic?
|
Haematology/ Biochemistry/ Molecular Genetics: CK levels, lactate levels, leucocyte counts, gene defects
|
Electrophysiology: EMG, nerve conduction velocities
|
Pathological features
|
Normal
|
|
-----
|
Myopathic
|
-----
|
|
?
|
|
Neurogenic
|
|
CT: fibrosis
|
-
|
+/+
|
++/+++
|
-/+
|
-/+++
|
-
|
-/+
|
-
|
-
|
-/++
|
Inflammation
|
-
|
++/++++
|
-/+
|
-
|
-
|
-
|
-/+
|
-
|
-
|
-
|
Fibre Size variation
|
CV<25%
|
+/+++
|
++/++++
|
-/++
|
-/++++
|
-/++
|
-/+
|
+/++++
|
-/+
|
+/+++
|
Regeneration
|
-
|
++/+++
|
++/++++
|
-/+
|
-/+
|
-
|
-/+
|
-/+
|
-
|
-
|
Morphological abnormalities
|
-
|
-
|
Hyaline fibres
Fibrosis
|
Vacuoles
|
Cores
Nemaline,
Internal nuclei
|
-
|
-/+
|
Angular
|
-
|
Grouped atrophy
|
Enzymes/storage
|
-
|
-
|
-
|
++/+++
|
Undifferentiated
|
Excess Type I fibres
|
-/+
|
FTG
|
AChE
|
-
|
Other Features
|
-
|
-
|
Absent dystrophin
|
Ragged red
|
Variable
|
NADH distribution
|
-/+
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
Pathological group
|
Normal
|
Inflammatory
|
Dystrophic
|
Metabolic
|
Congenital
|
Secondary / miscellaneous
|
?
|
Central
|
Junctional
|
Peripheral
|
Differential diagnoses (examples)
|
Normal
|
PM
DM
IBM
|
DMD
BMD
SCARMD
|
McArdle's
Pompe's
Mitochondrial
|
CFTD,
Central core,
Nemaline
|
Hypothyroid
Steroid
|
|
MND
SMA
|
MyG
LEMS
|
HMSN
|
pathology of cardiac muscle
· Myocardial hypertrophy
|
occurs in response to increased pressure overload.
At autopsy, an assessment of ventricular hypertrophy can be made by measuring the thickness of the ventricular walls.
This measurement is traditionally made 2 cm below the mitral or tricuspid valve, taking care not to include any papillary muscle(s).
Upper limits of normal are 0.4 cm for the right ventricle and 1.4 cm for the left ventricle.
Ventricular dilatation (as seen in failing hearts, or in volume overload as in valvular incompetence) can make a hypertrophic ventricular wall appear to be of normal thickness because the wall thins as the ventricular cavity dilates.
Right ventricular hypertrophy is commonly due to chronic lung disease ("chronic cor pulmonale").
Common causes of left ventricular hypertrophy are systemic hypertension (an increase in the peripheral resistance of the vasculature) and stenosis (narrowing) of the aortic valve (due to degenerative calcific aortic valve stenosis, chronic rheumatic valvular disease or a congenital bicuspid valve).
At a light microscopic level, hypertrophy can be recognized as in increase in the diameter of the cardiac muscle cells from a normal of about 15 um to 25 um or more.
The myocardium does not become hyperplastic because the cardiac muscle cells are one the permanent cell populations of the body (like the CNS neurones) and, in the adult, they have no replicative ability.
|
· Myocardial infarction
|
An infarct is an altered area of tissue which has lost its blood supply (ischaemia).
Infarction usually implies that the tissue has undergone ischaemic necrosis but this is not true for all infarcts e.g. a "red infarct" of the liver is not a true infarct but is due to sinusoidal engorgement and atrophy of liver cells.
Myocardial infarcts are true infarcts because each of the three main coronary arteries acts as an end artery (arteries of internal organs having imperfect anastomoses).
Because there are little or no anastomoses, little blood enters the dying myocardium, and so myocardial infarcts are pale infarcts.
Two types of myocardial infarction are recognized: transmural and subendocardial.
|
· Myocarditis
|
Inflammatory reactions within the myocardium are due to viruses and other infective agents, drugs, and autoimmune injury (hypersensitivity).
The histological appearances are variable but mononuclear infiltrates (lymphocytes, macrophages) are usually present
|
Myopathy: Congenital
|
Myopathic changes in central core disease: Adult (left) & Child (Right)
Fiber size: Variability
Connective tissue: Increased
Internal nuclei
|
|
NADH stain
|
ATPase, pH 9.4
|
 |
 |
Cores
Central zone, "core", in muscle fibers
ê Oxidative enzyme activity
ê Mitochondria
Cores run whole length of muscle fiber
|
Muscle fibers
Marked type I muscle fiber predominence
Some cores have loss of central myofibrillar structure
|
|
|
CENTRONUCLEAR (MYOTUBULAR) MYOPATHY
Infantile
H&E stain
|
ATPase stain, pH 9.4
|
Note central nuclei in
several small muscle fibers.
|
Type I (light) muscle fibers tend
to be smaller than type II.
Note clear regions in center of
some fibers.
|
NADH stain
|
VvG stain
|
Abnormal internal architecture.
Some fibers have central dark staining.
Others have coarse internal architecture.
|
Abnormal internal architecture.
Note clear rim around edge of
many fibers.
|
 |
Childhood
H&E stain
|
H&E stain
|
Note central nuclei in several smaller muscle fibers.
Central regions in other fibers are basophilic.
|
NADH stain
|
ATPase stain, pH 9.4
|
Abnormal internal architecture.
Some fibers have central dark staining.
Others have coarse internal architecture.
|
Type I (light) muscle fibers tend
to be smaller than type II.
Note clear regions in center of
some fibers.
|
 |
Juvenile
|
H&E stain
|
ATPase stain, pH 9.4
|
NADH stain
|
Central nuclei in several smaller
muscle fibers.
|
Type I (light) muscle fibers are
generally smaller than type II
(dark) fibers.
Note clear regions in center of
type I fibers.
|
Abnormal internal architecture
in smaller (type I) muscle fibers.
|
|
|
Myopathic changes in congenital muscular dystrophy
Fiber size: Variability
Immature muscle fibers (Center): Internal nuclei; Basophilia
Connective tissue (Right): Increased
|
|
Merosin: Normal muscle
Merosin is normally located in:
Basal lamina: Muscle fiber surface
Intramuscular nerves
|
Merosin: Congenital muscular dystrophy
Merosin staining is absent from
the muscle fiber surface
|
|
|
Congenital Fiber Type Size Disproportion:
Small type 1 Muscle fibers
INFANT
H&E stain
|
ATPase pH 9.4 stain
|
Congenital fiber type size disproportion in an infant.
Type 1 muscle fibers (pale on ATPase) are much smaller than type 2 fibers.
The large disparity in sizes of the 2 fiber types (> 50%) correlates
with a clinical picture of hypotonia and nonprogressive weakness.
CHILD
ATPase pH 4.3 stain
Type 1 muscle fibers (Dark) are small
|
Type 1 Fiber Smallness: Diffferential Diagnosis
Exercise training
|
|
NEMALINE RODS
Gomori trichrome
|
Electron microscopy of rods from Z-lines
|
Pathology
Light microscopy: Rods best visualized with Gomori trichrome stain (Upper Left)
Dark red-blue structures in muscle fiber cytoplasm
Composed of Z-line like material (Upper Right)
Contain a-actinin & tropomyosin ± desmin at the periphery
Located in sarcoplasm: Often in regions with disrupted sarcomere structure
Occur in
Congenital myopathies
Adult onset nemaline myopathies
Muscle fibers with targets
|
|
pathology of skeletal muscle
|
These patients usually present as floppy infants; the disease course is variable but most are non-progressive and some patients will have normal life expectancies. This is a heterogeneous group of diseases of which an example would be nemaline myopathy. Here rod-shaped inclusions are seen on longitudinal semithin sections or on sections stained with Gomori's trichrome method (a modified collagen stain).  The photomicrograph shows a Gomori's trichrome-stained tranverse section of quadriceps femoris from a 58-year-old woman with a 7 year history of gradual onset of muscle weakness. The myofilaments are stained green and the abnormal nemaline inclusions are stained deep red.  The electron photomicrograph shows the ultrastructure appearance of the nemaline inclusions. Immunohistochemical staining with a monoclonal antibody which recognizes alpha-actinin (the substance that forms the Z-lines where the actin filaments are anchored) shows that the nemaline inclusions are formed of alpha-actinin
|
|
 This is also a heterogeneous group of diseases of which the most important is the polymyositis/dermatomyositis group. They are characterized by inflammatory infiltrates of lymphocytes and macrophages. Immunohistochemical staining shows most of the lymphocytes are CD8 +ve T cells. There is rhabdomyolysis and rhabdomyophagia in the acute phase with a raised serum creatine phosphokinase level. Later stages show regenerating fibres with central nuclear chains and basophilic sarcoplasm. There is usually a perifascicular atrophy present. The disease can be quite focal within a muscle and so sampling can be a problem. A normal biopsy does not exclude polymyositis. Treatment is with steroids such as prednisolone. This photomicrograph of a quadriceps femoris biopsy shows transversely sectioned skeletal muscle fibres with those in the centre surrounded and infiltrated by a chronic inflammatory cell infiltrate composed mostly of lymphocytes. The infiltrate in this example is a fairly intense and many cases are more subtle then this. Immunohistochemical staining using anti-lymphoid antibodies can be very useful in borderline cases.
|
|
A number of specific metabolic abnormalities can cause muscle disorders. Examples would include periodic paralysis, glycogen and lipid storage diseases, and the mitochondrial myopathies (these are a large and heterogeneous group of diseases where there are abnormally large numbers of ultrastructurally abnormal mitochondria present within the sarcoplasm. Mitochondria can be seen on the oxidative enzyme stains [NADH and SDH] and more clearly by electron microscopy). Myopathies have also been described in association with several endocrine disorders, notably thyroid, parathyroid and pituitary disorders. Hyperadrenalism (Cushing's syndrome) and prolonged therapy with steroids (steroid myopathy) are both seen histologically as type II fibre atrophy. Type II atrophy is a fairly non-specific change seen in many chronic myopathies e.g. alcoholic myopathy. The photomicrograph shows a PAS-stained section of a quadriceps femoris skeletal muscle biopsy from a patient with a glycogen storage disease. Abnormal accumulations of glycogen can be seen within the sarcoplasm of many of the skeletal muscle fibres
|
|
Lower motor neurone diseases include peripheral neuropathies (most commonly caused by diabetes mellitus although there are many other causes), poliomyelitis, amyotrophic lateral sclerosis and spinal muscular atrophy. Lower motor neurone diseases cause a neurogenic atrophy characterized by random atrophy of type II skeletal muscle fibres that are angulated on transverse sections. "Target" skeletal muscle fibres, resembling the pattern on a dartboard, are commonly revealed by oxidative enzyme staining (NADH, SDH). If it occurs, reinnervation of the skeletal muscle leads to fibre type grouping which contrasts with the chequer-board mosaic seen in normal skeletal muscle biopsies. The photomicrograph shows a transverse section of a quadriceps femoris skeletal muscle biopsy stained for NADH. Fibre type grouping is evident (the type I skeletal muscle fibres are darkly stained and type II skeletal muscle fibres lightly stained in this preparation) and the normal chequer-board mosiac pattern is lost. Fibre type grouping is said to have occured when groups of 6 or more fibres of the same type can be found in the skeletal muscle biopsy.
|
|
This is a group of hereditary primary myopathies. They show a chronic and progressive clinical course. The commonest forms are Duchenne muscular dystrophy, Becker dystrophy, limb girdle dystrophy, and myotonic dytrophy. Muscle biopsies show scattered necrotic fibres and hypertrophied fibres.
|
Dr Jon Salisbury, http://www.smd.kcl.ac.uk/kcsmd/hist/chap3.htm#cardiac%20muscle
|